Effects of RNAi-mediated Smad4 silencing on growth and apoptosis of human rhabdomyosarcoma cells

International Journal of Oncology

Volumn 29, Issue 5, 2006, Pages 1149-1157

  Ye, Lv ^a   Zhang, Hongying ^a   Zhang, Li ^a   Yang, Guanghua ^a   Ke, Qi ^a   Guo, Hua ^a   Bu, Hong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Rhabdomyosarcoma; RNA interference; Smad4; Transforming growth factor 1

Indexed keywords

MESSENGER RNA; SMAD4 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL NUCLEUS; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENE SILENCING; GENETICS; HUMAN; METABOLISM; PATHOLOGY; RHABDOMYOSARCOMA; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL NUCLEUS; CELL PROLIFERATION; GENE EXPRESSION; GENE SILENCING; HUMANS; RHABDOMYOSARCOMA; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 33847191761     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.5.1149     Document Type: Article

References (48)

1. Massague J and Chen YG: Controlling TGF-β signaling. Genes Dev 14: 627-644, 2000.
2. Yue J and Muler KM: Transforming growth factor β signal transduction in epithelial cells. Pharmacol Ther 91: 1-34, 2001. (Pubitemid 33055772)
3. Massague J and Wotton D: Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 19: 1745-1754, 2000. (Pubitemid 30204386)
4. Ten Dijke P, Miyazono K and Heldin CH: Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends Biochem Sci 25: 64-70, 2000. (Pubitemid 30100368)
5. Miyazono K, Ten Dijke P and Heldin CH: TGF-beta signaling by Smad proteins. Adv Immunol 75: 115-157, 2000.
6. Pappo AS, Shapiro DN and Crist WM: Rhabdomyosarcoma: biology and treatment. Pediatr Clin North Am 44: 953-972, 1997.
7. Dagher R and Hellman L: Rhabdomyosarcoma: an overview. Oncologist 4: 34-44, 1999.
8. El-Badry OM, Minniti C, Kohn EC, Houghton PJ, Daughaday WH and Helman LJ: Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth Differ 1: 325-331, 1990.
9. Schweigerer L, Neufeld G, Mergia A, Abraham JA, Fiddes JC and Gospodarowicz D: Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors. Proc Natl Acad Sci USA 84: 842-846, 1987. (Pubitemid 17033903)
10. De Giovanni C, Landuzzi L, Frabetti F, Nicoletti G, Griffoni C, Rossi I, Mazzotti M, Scotto L, Nanni P and Lollini PL: Antisense epidermal growth factor receptor transfection impairs the proliferative ability of human rhabdomyosarcoma cells. Cancer Res 56: 3898-3901, 1996. (Pubitemid 26284736)
11. Bouche M, Canipari R, Melchionna R, Willems D, Senni MI and Molinaro M: TGF-beta autocrine loop regulates cell growth and myogenic differentiation in human rhabdomyosarcoma cells. FASEB J 14: 1147-1158, 2000. (Pubitemid 30350397)
12. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE and Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811, 1998.
13. Hannon GJ: RNA interference. Nature 418: 244-251, 2002.
14. Carrington JC and Ambros V: Role of microRNAs in plant and animal development. Science 301: 336-338, 2003. (Pubitemid 36877060)
15. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498, 2001. (Pubitemid 32494397)
16. Bernstein E, Caudy AA, Hammond SM and Hannon GJ: Role for a bidentate ribonucleasa in the initiation step of RNA interference. Nature 409: 363-366, 2001. (Pubitemid 32151243)
17. Yu JY, De Ruiter SL and Turner DL: RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 99: 6047-6052, 2002.
18. Ling X and Li F: Silencing of antiapoptotic surviving gene by multiple approaches of RNA interference technology. Biotechniques 36: 450-460, 2004.
19. Wang H, Yang GH, Bu H, Zhou Q, Guo LX, Wang SL and Ye L: Systematic analysis of the TGF-beta/smad signalling pathway in the rhabdomyosarcoma cell line RD. Int J Exp Pathol 84: 115-125, 2003.
20. Elbashir SM, Harborth J, Weber K and Tuschl T: Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213, 2002.
21. Ye L, Zhang HY, Wang H, Yang GH, Bu H, Zhang L and Wang SL: Effects of transforming growth factor beta 1 on the growth of rhabdomyosarcoma cell line RD. Chin Med J (Engl) 118: 678-686, 2005. (Pubitemid 40585031)
22. Holen T, Amarzguioui M, Wiiger MT, Babaie E and Prydz H: Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res 30: 1757-1766, 2002.
23. Roberts AB, Anzano MA, Lamb LC, Smith JM and Sporn MB: New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 78: 5339-5343, 1981.
24. Mazars A, Tournigand C, Mollat P, Prunier C, Ferrand N, Bourgeade MF, Gespach C and Atfi A: Differential roles of JNK and Smad2 signaling pathways in the inhibition of c-Myc-induced cell death by TGF-β. Oncogene 19: 1277-1287, 2000.
25. Alexandrow MG and Moses HL: Transforming growth factor β and cell cycle regulation. Cancer Res 55: 1452-1457, 1995.
26. Wimmel A, Wiedenmann B and Rosewicz S: Autocrine growth inhibition by transforming growth factor beta-1 (TGF-β-1) in human neuroendocrine tumour cells. Gut 52: 1308-1316, 2003.
27. Miyazaki M, Sakaguchi M, Akiyama I, Sakaguchi Y, Nagamori S and Huh NH: Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells. Cancer Res 64: 4155-4161, 2004.
28. Kamaraju AK and Roberts AB: Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J Biol Chem 280: 1024-1036, 2005.
29. Laiho M, De Caprio JA, Ludlow JW, Livingston DM and Massague J: Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62: 175-185, 1990.
30. Ammanamanchi S, Tillekeratne MP, Ko TC and Brattain MG: Endogenous control of cell cycle progression by autocrine transforming growth factor beta in breast cancer cells. Cancer Res 64: 2509-2515, 2004.
31. Scandura JM, Boccuni P, Massague J and Nimer SD: Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc Natl Acad Sci USA 101: 15231-15236, 2004.
32. De Lujan Alvarez M, Ronco MT, Ochoa JE, Monti JA, Carnovale CE, Pisani GB, Lugano MC and Carrillo MC: Interferon alpha-induced apoptosis on rat preneoplastic liver is mediated by hepatocytic transforming growth factor beta(1). Hepatology 40: 394-402, 2004.
33. Danforth DN Jr: All trans-retinoic acid acts synergistically with hydroxytamoxifen and transforming-growth factor beta to stimulate apoptosis in MCF-7 breast cancer cells. J Endocrinol 183: 395-404, 2004.
34. Nawshad A, La Gamba D and Hay ED: Transforming growth factor beta (TGF-beta) signaling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT). Arch Oral Biol 49: 675-689, 2004.
35. Arsura M, Panta GR, Bilyeu JD, Cavin LG, Sovak MA, Oliver AA, Factor V, Heuchel R, Mercurio F, Thorgeirsson SS and Sonenshein GE: Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Oncogene 22: 412-425, 2003.
36. Jung YJ, Kim JY and Park JH: TGF-beta1 inhibits Fas-mediated apoptosis by regulating surface Fas and cFLIPL expression in human leukaemia/lymphoma cells. Int J Mol Med 13: 99-104, 2004.
37. Peng B, Fleming JB, Breslin T, Grau AM, Fojioka S, Abbruzzese JL, Evans DB, Ayers D, Wathen K, Wu T, Robertson KD and Chiao PJ: Suppression of tumorigenesis and induction of p15 (ink4b) by Smad4/DPC4 in human pancreatic cancer cells. Clin Cancer Res 8: 3628-3638, 2002.
38. Hahn SA, Bartsch D, Schroers A, Galehdari H, Becker M, Ramaswamy A, Schwarte-Waldhoff I, Maschek H and Schmiegel W: Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. Cancer Res 58: 1124-1126, 1998.
39. Mikami T, Ookawa K, Shimoyama T, Fukuda S, Saito H and Munakata A: KAI1, CAR, and Smad4 expression in the progression of colorectal tumor. J Gastroenterol 36: 465-469 2001.
40. Dai JL, Bansal RK and Ken SE: G1 cell cycle arrest and apoptosis induction by nuclear Smad4/DPC4: phenotypes reversed by a tumorigenic mutation. Proc Natl Acad Sci USA 96: 1427-1432, 1999.
41. Ramachandra M, Atencio I, Rahman A, Vaillancourt M, Zou A, Avanzini J, Wills K, Bookstein R and Shabram P: Restoration of transforming growth factor Beta signaling by functional expression of smad4 induces anoikis. Cancer Res 62: 6045-6051, 2002.
42. Atfi A, Buisine M, Mazars A and Gespach C: Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-beta through stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling pathway. J Biol Chem 272: 24731-24734, 1997.
43. Moustakas A and Heldin CH: Non-Smad TGF-beta signals. J Cell Sci 118: 3573-3584, 2005.
44. Xia H, Mao Q, Paulsen HL and Davidson BL: siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 20: 1006-1010, 2002.
45. Lewis L, Hagstrom JE, Loomis AG, Wolff JA and Herweijer H: Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 32: 107-108, 2002 .
46. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, and Kay MA: RNA interference in adult mice. Nature 418: 38-39, 2002.
47. Morris MC, Chaloin L, Heitz F and Divita G: Translocating peptides and proteins and their use for gene delivery. Curr Opin Biotechnol 11: 461-466, 2000.
48. Ritter K, Benavente A, Bompard-Sorlet A, Heitz F, Divita G, Brasseur R and Jacobs E: New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. Mol Ther 5: 104-114, 2002.